title: Establishment of mice model with human viral hepatitis B.
abstract: OBJECTIVE
  To establish a mice model of hepatitis B by using HBV-transgenic mice, and to transfer HBV-specific cytotoxic T lymphocytes (CTL) induced from syngeneic BALB/c mice immunized by a eukaryotic expression vector containing HBV complete genome DNA.
  
  
  METHODS
  HBV DNA was obtained from digested pBR322-2HBV and ligated with the vector pcDNA3. Recombinant pcDNA3-HBV was identified by restriction endonuclease assay and transfected into human hepatoma cell line HepG2 with lipofectin. ELISA was used to detect the expression of HBsAg in culture supernatant, and RT-PCR to determine the existence of HBV PreS1 mRNA. BALB/c mice were immunized with pcDNA3-HBV or pcDNA3 by intramuscular injection. ELISA was used to detect the expression of HBsAb in serum. MTT assay was used to measure non-specific or specific proliferation ability and specific killing activity of spleen lymphocytes. Lymphocytes from immunized mice were transferred into HBV-transgenic mice (2.5X10(7) per mouse). Forty-eight hours later, the level of serum protein and transaminase was detected with biochemical method, liver and kidney were sectioned and stained by HE to observe the pathological changes.
  
  
  RESULTS
  By enzyme digestion with Eco RI, Xho I and Hind III, the recombinant pcDNA3-HBV was verified to contain a single copy of HBV genome, which was inserted in the positive direction. HepG2 cells transfected with the recombinant could stably express PreS1 mRNA and HBsAg. After immunized by pcDNA3-HBV for 4 weeks, HBsAb was detected in the serum of BALB/c mice. The potential of spleen lymphocytes for both non-specific and specific proliferation and the specific killing activity against target cells were enhanced. The transgenic mice in model group had no significant changes in the level of serum protein but had an obvious increase of ALT and AST. The liver had obvious pathological changes, while the kidney had no evident damage.
  
  
  CONCLUSIONS
  A eukaryotic expression vector pcDNA3-HBV containing HBV complete genome is constructed successfully. HepG2 cells transfected with the recombinant can express PreS1 mRNA and HBsAg stably. Specific cellular immune response can be induced in mice immunized by pcDNA3-HBV. A mice model of acute hepatitis with HBV has been established.
authors.affiliation: Institute of Immunology, Medical College, Shandong University, Jinan 250012, Shandong Province, China.
authors.forename: Li-Fen
authors.initials: LF
authors.lastname: Gao
authors.forename: Wen-Sheng
authors.initials: WS
authors.lastname: Sun
authors.forename: Chun-Hong
authors.initials: CH
authors.lastname: Ma
authors.forename: Su-Xia
authors.initials: SX
authors.lastname: Liu
authors.forename: Xiao-Yan
authors.initials: XY
authors.lastname: Wang
authors.forename: Li-Ning
authors.initials: LN
authors.lastname: Zhang
authors.forename: Ying-Lin
authors.initials: YL
authors.lastname: Cao
authors.forename: Fa-Liang
authors.initials: FL
authors.lastname: Zhu
authors.forename: Yu-Gang
authors.initials: YG
authors.lastname: Liu
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D004279:DNA, Viral; D004195:Disease Models, Animal; D016679:Genome, Viral; D006509:Hepatitis B / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008822:Mice, Transgenic; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000637:transplantation*; D014162:Transfection
chemical_list: D004279:DNA, Viral